Date: Tue 08 Jul, 2025
Notice has been issued that the Twenty-Fourth (24th) Annual General Meeting (“AGM”) of the shareholders of BVG India Limited (“the Company”) is scheduled to be held on Thursday, July 31, 2025 at 12:30 PM IST at the Corporate Office of the Company, located at MIDAS Tower, 4th Floor, Phase I, Rajiv Gandhi Infotech Park, Hinjewadi, Pune – 411057, to transact the business as outlined in the agenda below:
Ordinary Business:
Adoption of Financial Statements: Approval of standalone and consolidated audited financial statements for FY ending March 31, 2025.
Declaration of Preference Dividend: Approval of ₹0.0001 per compulsorily convertible cumulative preference share (₹10 face value) for FY 2024–25.
Declaration of Equity Dividend: Approval of ₹1.25 per equity share (₹2 face value) for FY 2024–25.
Re-appointment of Director: Mr. Pankaj Dhingra (Non-Executive Director) retires by rotation and seeks re-appointment.
Remuneration of Statutory Auditors: Authorizing the Board to fix remuneration of M/s MSKA & Associates for FY 2025–26.
Special Business:
Re-appointment of Mr. Chandrakant Dalvi: As Non-Executive Independent Director for a second 5-year term (Oct 2024–Oct 2029).
Re-appointment of Mr. Prabhakar Karandikar: As Non-Executive Independent Director for a second 5-year term (Feb 2025–Feb 2030), despite being above 75 years (requires special approval as per SEBI norms).
Re-appointment of Mr. Rajendra Nimbhorkar: As Non-Executive Independent Director for a second 5-year term (Feb 2025–Feb 2030).
Appointment of Mrs. Neha Huddar: As a new Non-Executive Independent Director for a 5-year term (Mar 2025–Mar 2030).
Initial Public Offering (IPO) Approval: Approval for the Company to raise up to ₹400 crore through a fresh issue of equity shares and offer for sale (OFS) by existing shareholders.
In conclusion, the 24th Annual General Meeting of BVG India Limited encompasses key matters vital to the Company's continued governance, financial performance, and strategic growth.
Date: Tue 08 Jul, 2025
Notice of the Extra Ordinary General Meeting ("EGM") of IKF Finance Limited, which is scheduled for Thursday, 31st July 2025 at 11:30 a.m. (IST) at the Registered Office of the Company situated at #40-1-144, 3rd Floor, Corporate Centre, M.G. Road, Vijaywada-520010, Andhra Pradesh to transact the following special businesses:
Special Business:
Date: Tue 08 Jul, 2025
Notice of the 34th Annual General Meeting ("AGM") of Hero Fincorp Limited, which is scheduled for Monday, 28th July 2025 at 12:00 p.m. (IST) through video conferencing (“VC”)/ other audio-visual means (“OAVM”) to transact the following businesses:
Ordinary Business:
To receive, consider and adopt:
Instructions at glance
Cut-off date | Monday, July 21, 2025 |
Commencement of remote e-voting | Friday, July 25, 2025 at 9:00 AM |
End of remote e-voting | Sunday, July 27, 2025 at 5:00 PM |
AGM | Monday, July 28, 2025 at 12:00 PM |
Date: Sat 05 Jul, 2025
The SME IPO segment demonstrated robust activity in the first half of 2025. From January to June 2025, approximately 94 SME IPOs were launched, collectively raising a total of around ₹4,138.28 crore. This underscores a vibrant SME IPO ecosystem and strong capital-raising momentum among small and medium enterprises in India.
Despite new SEBI rules that doubled the minimum investment in SME IPOs from ₹1 lakh to ₹2 lakh effective March 2025, investor enthusiasm remained strong. Several IPOs across SME achieved significant positive listings, indicating strong investor confidence and successful market debuts.
For the SME segment, Neetu Yoshi showed substantial gains with listing at 40% Premium. Other notable SME IPOs with positive listings include Fabtech Technologies Cleanrooms Limited, Sat Kartar Shopping Limited and Monolithisch India, all listed in January 2025.
Date: Fri 04 Jul, 2025
Date: Mon 30 Jun, 2025
Financial Performance (FY25 vs FY24):
Anglo-French Drugs posted a 18.2% YoY growth in total income to ₹118.0 Cr in FY25, up from ₹100 Cr in FY24, driven by a strong surge in other income (₹30 Cr vs ₹4.5 Cr), partially offset by a 7.8% decline in core revenue from operations to ₹88 Cr from ₹95 Cr. This indicates pressure on the core pharmaceutical business. Despite lower operational revenue, profit before tax (PBT) turned positive to ₹8 Cr from a loss of ₹12 Cr in FY24. The turnaround was largely due to investment gains and reduced raw material costs.
Operational Metrics (FY25 vs FY24):
Net profit margin improved to 6.1% from –12.4%, aided by cost control and higher other income. Total borrowings doubled to ₹19 Cr, primarily for working capital. A related-party loan of ₹7.52 Cr to Dormirbien Pvt Ltd raised governance concerns. Net cash from operations stood at ₹2 Cr, while cash and cash equivalents rose marginally. The company also invested ₹54 Cr and spent ₹9.0 Cr in capex for the acquisition of assets indicating a tilt toward treasury income.
Strategic Developments:
FY25 was a transformation year for AFDIL, marked by a turnaround in profitability after consecutive losses. However, core pharma revenues declined, reflecting underlying demand pressure and execution issues, especially in exports (which fell from ₹9 Cr to ₹0.93 Cr YoY). The company’s strategic buyback of shares (₹53 Cr payout) and lending to a related startup (DPL) raise capital allocation concerns. The shift towards high-yield investments helped earnings but raises questions on sustainability.
Date: Wed 25 Jun, 2025
HDB Financial Services, a leading non-banking financial company (NBFC) and a subsidiary of HDFC Bank, is preparing for a significant Initial Public Offering (IPO) in the Indian market. This public issue is generating substantial interest due to HDB's strong backing and its integral role in India's retail and SME lending landscape.
HDB Financial Services plays a pivotal role in serving underbanked and semi-urban segments through a diversified product portfolio that includes enterprise lending, asset finance, and consumer loans. Its extensive pan-India presence, combined with a robust digital infrastructure, has propelled HDB into a formidable position within the financial services landscape.
The IPO is significant not only for its size, aiming to raise ₹12,500 crore, but also as a strategic move to comply with Reserve Bank of India (RBI) regulations requiring "upper-layer" NBFCs to be publicly listed by September 2025.
Date: Thu 19 Jun, 2025
Small and Medium Enterprises (SMEs) are the backbone of India’s economy, driving innovation, employment, and regional development. Investing in the SME sector provides a unique opportunity for investors to participate in the growth of emerging companies with high potential.
However, navigating this landscape requires insight into which investors have successfully generated substantial returns by backing promising SMEs. Let’s dive into the top investors who have consistently identified high-growth potential in smaller and emerging enterprises, delivered impressive returns, and set benchmarks for strategic and impactful investment in this vibrant sector.
Collectively, these investors showcase deep analytical rigour, long-term conviction, and a willingness to back lesser-known companies, often resulting in compound annual returns exceeding 20-30% and, in many cases, life-changing multi-bagger exits. Their stories not only define benchmarks for SME investing in India but also inspire a new generation of private market participants to seek value, patience, and vision as drivers of enduring wealth creation.
Date: Thu 19 Jun, 2025
HDB Financial Services and Cholamandalam Investment & Finance Company both demonstrate strong financial performance in FY25, with Cholamandalam leading in most key metrics. Cholamandalam Investment & Finance Company is an established and listed NBFC that currently leads HDB Financial Services in terms of scale and profitability.
Cholamandalam reports revenue of Rs 25,846 crore compared to HDB’s Rs 16,300 crore, along with superior profitability indicators such as a PAT of Rs 4,263 crore and a higher ROE of 19.8%. Additionally, Cholamandalam’s asset under management (AUM) and total disbursement significantly surpass HDB’s, reflecting its larger scale of operations.
Date: Tue 17 Jun, 2025
Date: Mon 16 Jun, 2025
Date: Fri 13 Jun, 2025
Date: Wed 11 Jun, 2025
The Indian IPO market has entered a new phase of momentum in 2025, distinguishing itself from earlier speculative cycles by focusing on genuine, sizable offerings spanning tech, finance, renewables, and market infrastructure sectors.
After a tentative start to the year, a substantial post-April rebound has delivered new vibrancy, as companies like HDB Financial Services, Zepto, Vikram Solar, NSDL,Imagine Marketing (boAt) and the National Stock Exchange (NSE) prepare for long-awaited public debuts.
Date: Tue 10 Jun, 2025
Date: Thu 05 Jun, 2025
Notice is hereby given that the 20th (Twentieth) Annual General Meeting (AGM) of the Shareholders of Shriram Life Insurance Company Limited (referred to as "the Company") will be held on Wednesday, June 25, 2025. The meeting will take place at Plot No. 31 & 32, 5th Floor, Ramky Selenium, Financial District, Gachibowli, Hyderabad — 500 032, starting at 11:30 AM. The agenda will include the following business matters:
Ordinary Business:
Special Business:
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.